Tristel (TSTL) RNS Announcements

Add to Alert list
Date Time Source Announcement
24 Nov 2025 12:28 PM
RNS
Director Option Grant
24 Nov 2025 07:00 AM
RNS
Updated US guidelines for high level disinfection
18 Nov 2025 07:00 AM
RNS
Notice of AGM & Posting of Annual Report &Accounts
12 Nov 2025 11:33 AM
RNS
Holding(s) in Company
31 Oct 2025 04:11 PM
RNS
Holding(s) in Company
31 Oct 2025 02:12 PM
RNS
Holding(s) in Company
22 Oct 2025 04:56 PM
RNS
Holding(s) in Company
16 Oct 2025 04:00 PM
RNS
Exercise of Share Options and Total Voting Rights
13 Oct 2025 12:00 PM
RNS
Exercise of Share Options and Total Voting Rights
13 Oct 2025 07:00 AM
RNS
Final Results
09 Oct 2025 10:06 AM
RNS
Exercise of Share Options and Total Voting Rights
25 Sep 2025 07:00 AM
RNS
VISICLEAN Product Launch
16 Sep 2025 07:00 AM
RNS
Notice of Preliminary Results
11 Sep 2025 07:00 AM
RNS
Exercise of Share Options and Total Voting Rights
01 Sep 2025 07:00 AM
RNS
Confirmation of CFO Appointment
21 Aug 2025 03:56 PM
RNS
Holding(s) in Company
18 Aug 2025 12:15 PM
RNS
Exercise of Share Options and Total Voting Rights
06 Aug 2025 04:05 PM
RNS
Capital Markets Day video update
29 Jul 2025 07:00 AM
RNS
Trading update
24 Jul 2025 07:00 AM
RNS
Confirmation of Investor presentations
17 Jul 2025 07:00 AM
RNS
Appointment of Chief Financial Officer
04 Jul 2025 01:02 PM
RNS
Holding(s) in Company
26 Jun 2025 07:00 AM
RNS
APIC25 Annual Conference attendance
02 Jun 2025 07:00 AM
RNS
Investor Presentations & Notice of Trading Update
30 May 2025 07:00 AM
RNS
Holding(s) in Company
28 May 2025 07:00 AM
RNS
Conference attendance at Mello2025 Investor event
16 May 2025 07:00 AM
RNS
Exercise of Share Options and Total Voting Rights
15 May 2025 07:00 AM
RNS
CFO succession planning
12 May 2025 07:00 AM
RNS
FDA clearance for Tristel OPH
10 Apr 2025 07:00 AM
RNS
Additional info. submitted to FDA for Tristel OPH
09 Apr 2025 07:00 AM
RNS
Publication of Poster by Mayo Clinic & US update
02 Apr 2025 07:00 AM
RNS
Director/PDMR Shareholding
31 Mar 2025 08:56 AM
RNS
Holding(s) in Company
26 Mar 2025 10:30 AM
RNS
Director/PDMR Shareholding
18 Mar 2025 02:39 PM
RNS
Holding(s) in Company
24 Feb 2025 07:00 AM
RNS
Unaudited Interim Results
07 Feb 2025 07:00 AM
RNS
Exercise of Share Options and Total Voting Rights
23 Jan 2025 07:00 AM
RNS
Director Option Grant
13 Jan 2025 07:00 AM
RNS
Confirmation of Interim Results
16 Dec 2024 02:45 PM
RNS
Result of AGM
16 Dec 2024 07:00 AM
RNS
AGM Statement and Notice of Interim Results
22 Nov 2024 10:30 AM
RNS
Notice of AGM & Posting of Annual Report &Accounts
21 Nov 2024 01:32 PM
RNS
Exercise of Share Options and Total Voting Rights
20 Nov 2024 08:47 AM
RNS
Exercise of Share Options and Total Voting Rights
28 Oct 2024 01:37 PM
RNS
Exercise of Share Options and Total Voting Rights
21 Oct 2024 07:00 AM
RNS
Final Results
01 Oct 2024 07:00 AM
RNS
Notice of Preliminary Results
20 Sep 2024 07:00 AM
RNS
Director/PDMR Shareholding
19 Sep 2024 01:13 PM
RNS
Exercise of Share Options and Total Voting Rights
12 Sep 2024 07:00 AM
RNS
FDA 510(k) submission for Tristel OPH

Tristel plc is a global infection prevention company focused on manufacturing and supplying products using its proprietary chlorine dioxide (ClO2) chemistry, with a focus on medical device decontamination and surface disinfection.

Tristel share price launched at 46p in 2005.

UK 100